CLINICAL_TRIALS
trial_result
· 2012-09-27
Clinical Trial Update: Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer [Phase 3]
Summary
Phase 3 neoadjuvant trial evaluating degarelix in prostate cancer has completed and results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ferring Pharmaceuticals | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2012-09-27